157 Spam-Free Article(s) Found
Sort:
Date
Filter:
All
Symbol Name Last Close Mkt Cap DailyStocks'
Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Thursday’s Close
NVO Novo Nordisk A/S $47.64 $114.84B Downtrend
Article Searches
Novo Nordisk's (NVO) Hits 52-Week High: What's Driving It? http://www.zacks.com/stock/news/289135/novo-nordisks-nvo-hits-52-week-high-whats-driving-it?cid=CS-ZC-FT-289135 Jan 17, 2018 - Regulatory approvals of some key pipeline candidates along with the strong performance of products like Victoza have contributed to a rally in Novo Nordisk's (NVO) shares.
Teva's Trisenox Gets FDA Approval as First-Line Treatment http://www.zacks.com/stock/news/288993/tevas-trisenox-gets-fda-approval-as-first-line-treatment?cid=CS-ZC-FT-288993 Jan 16, 2018 - Teva Pharmaceutical (TEVA) receives approval from the FDA for label expansion of its leukemia drug, Trisenox, in first-line setting.
Foreign Stock Roundup: Infosys Beats; AstraZeneca's Asthma Drug Gets Approval in EU http://www.zacks.com/stock/news/288847/foreign-stock-roundup-infosys-beats-astrazenecas-asthma-drug-gets-approval-in-eu?cid=CS-ZC-FT-288847 Jan 15, 2018 - Global markets endured a volatile week, guided by opposing factors.
Pharma Stock Roundup: Novo Nordisk Reveals Bid to Acquire Ablynx, Pfizer & Others at Healthcare Conference http://www.zacks.com/stock/news/288624/pharma-stock-roundup-novo-nordisk-reveals-bid-to-acquire-ablynx-pfizer-others-at-healthcare-conference?cid=CS-ZC-FT-288624 Jan 12, 2018 - Focus this week was on pipeline updates provided by several companies including Pfizer (PFE) at a healthcare conference while Novo Nordisk's bid to acquire Ablynx also made news.
Why is Novo Nordisk Stock Up More Than 50% in Past Year? http://www.zacks.com/stock/news/288483/why-is-novo-nordisk-stock-up-more-than-50-in-past-year?cid=CS-ZC-FT-288483 Jan 11, 2018 - We take a look at the factors that led to the rise in Novo Nordisk's (NVO) share price in the past year.
Eli Lilly & Co. at J.P. Morgan: 5 Things Investors Will Want to Know https://www.fool.com/investing/2018/01/10/eli-lilly-co-at-j-p-morgan-5-things-investors-will.aspx?source=iedfolrf0000001 Jan 10, 2018 - What's Lilly's next stage of growth? CEO Dave Ricks answered this question and more at the J.P. Morgan Healthcare Conference.
Novo Nordisk's Ozempic Gets Canadian Approval for Diabetes http://www.zacks.com/stock/news/288414/novo-nordisks-ozempic-gets-canadian-approval-for-diabetes?cid=CS-ZC-FT-288414 Jan 10, 2018 - Novo Nordisk (NVO) announced that Health Canada has approved Ozempic to improve glycemic control in adults with type II diabetes mellitus.
Novo Nordisk Confirms Bid for Ablynx But Faces Rejection http://www.zacks.com/stock/news/288271/novo-nordisk-confirms-bid-for-ablynx-but-faces-rejection?cid=CS-ZC-FT-288271 Jan 09, 2018 - Novo Nordisk (NVO) confirmed its revised offer made on Dec 22, to acquire Ablynx NV for $3.1 billion.
5 Biggest New Drugs of 2018 -- and How You Can Profit From Their Makers https://www.fool.com/investing/2018/01/07/5-biggest-new-drugs-of-2018-and-how-you-can-profit.aspx?source=iedfolrf0000001 Jan 07, 2018 - These new drugs could make billions of dollars for big drugmakers. And they could make you money, too.
3 Large-Cap Pharma Stocks to Watch Out for This New Year http://www.zacks.com/stock/news/287868/3-large-cap-pharma-stocks-to-watch-out-for-this-new-year?cid=CS-ZC-FT-287868 Jan 04, 2018 - We take a look at a few Large Cap drug stocks with a favorable combination of Zacks Rank and VGM Score. The stocks are poised to carry on their bull run this year too.

Pages: 1...4567891011121314...16

<<<Page 9>